EDGEWISE THERAPEUTICS INC (EWTX)

US28036F1057 - Common Stock

30.78  -0.02 (-0.06%)

After market: 30.78 0 (0%)

Full estimates are only available for subscribed users, you can see which data is available below.

Subscribed users also see more surprise data, now it is restricted to 4 quarters.

Examples of complete estimate data are available for MSFT and AAPL.

Registered users have access to more data. Please register or login for additional estimates and surprises .

Yearly Revenue, EBIT, EBITDA and EPS Analyst Estimates
2019 2020 2021 2022 2023 2024 2025 2026 2027 2028 2029 2030 2031
Revenue
YoY % growth
N/AN/AN/AN/A
1,142.63%
N/A
235.85%
N/A
121.79%
N/A
84.17%
N/A
52.28%
EBITDA
YoY % growth
-9.8M-17M
-73.47%
-42.95M
-152.65%
-71.29M
-65.98%
-112.806M
-58.24%
N/A
-38.67%
N/A
-20.09%
N/A
-16.81%
N/A
6.97%
N/A
100.45%
N/A
45,742.31%
N/A
147.33%
N/A
60.17%
EBIT
YoY % growth
-9.92M-17.19M
-73.29%
-43.22M
-151.43%
-71.66M
-65.80%
-114.357M
-59.58%
N/A
-38.50%
N/A
-25.89%
N/A
-18.64%
N/A
-9.43%
N/A
49.16%
N/A
176.43%
N/A
310.93%
N/A
94.81%
Operating Margin
N/AN/AN/AN/AN/AN/AN/AN/AN/AN/AN/AN/AN/A
EPS
YoY % growth
N/AN/A-0.87-1.27
-45.98%
-1.58
-24.41%
N/A
3.49%
N/A
-22.32%
N/A
-14.52%
N/A
-19.13%
N/A
45.69%
N/A
156.27%
N/A
388.85%
N/A
74.98%

All data in USD

Quarterly Revenue, EBIT, EBITDA and EPS Analyst Estimates
Q4 / 24 Q1 / 25 Q2 / 25 Q3 / 25 Q4 / 25 Q1 / 26 Q2 / 26 Q3 / 26 Q4 / 26
EPS
Q2Q % growth
-0.40
14.74%
-0.39
-16.84%
-0.42
-24.80%
-0.46
-27.50%
-0.49
-23.45%
-0.53
-37.57%
-0.54
-27.40%
-0.57
-24.44%
-0.60
-21.65%
Revenue
Q2Q % growth
N/AN/AN/AN/A
EBITDA
Q2Q % growth
-41.786M
-29.33%
-43.254M
-26.18%
-45.774M
-23.20%
-51.352M
-31.87%
-54.378M
-30.13%
N/AN/AN/AN/A
EBIT
Q2Q % growth
-42.877M
-26.62%
-43.795M
-26.02%
-46.625M
-22.35%
-50.537M
-24.99%
-55.639M
-29.76%
-56.814M
-29.73%
-57.883M
-24.15%
-60.957M
-20.62%
-63.773M
-14.62%

All data in USD

Recent Earnings VS Estimates Surprises (USD)
PeriodReportedEstimateDifferenceSurprise
Q3 2024
Q2Q % growth
-0.36
12.20%
-0.380.024.98%
Q2 2024
Q2Q % growth
-0.34 -0.350.013.18%
Q1 2024
Q2Q % growth
-0.33
8.33%
-0.400.0717.47%
Q4 2023
Q2Q % growth
-0.47
-51.61%
-0.44-0.03-6.17%
Q3 2023
Q2Q % growth
-0.41
-20.59%
-0.40-0.01-1.51%
Q2 2023
Q2Q % growth
-0.34
-6.25%
-0.410.0716.25%
Q1 2023
Q2Q % growth
-0.36
-20.00%
-0.370.011.96%
Q4 2022
Q2Q % growth
-0.31
-19.23%
-0.340.039.55%
Q3 2022
Q2Q % growth
-0.34
-30.77%
-0.360.026.37%
Q2 2022
Q2Q % growth
-0.32
-52.38%
-0.330.013.17%
Q1 2022
Q2Q % growth
-0.30
-114.29%
-0.28-0.02-5.80%
Q4 2021
Q2Q % growth
-0.26 -0.25-0.01-2.99%
Q3 2021
Q2Q % growth
-0.26 -0.23-0.03-14.14%
Q2 2021
Q2Q % growth
-0.21 -0.18-0.03-15.99%
Q1 2021
Q2Q % growth
-0.14 -0.160.0212.85%
Recent Revenue VS Estimates Surprises (USD)
PeriodReportedEstimateDifferenceSurprise
EPS and Revenue Revisions
Next Q (1 month) Next Q (3 month) Next Year (1 month) Next Year (3 month)
EPS0.96% 0.36% -0.53% -0.24%
RevenueN/A N/A N/A N/A